Latanoprost/timolol explained

Latanoprost/timolol, sold under the brand name Xalacom, is a combination drug used for the treatment of glaucoma, consisting of latanoprost (increase uveoscleral outflow of aqueous humor[1]) and timolol (a beta blocker decreasing the production of aqueous fluid).

Society and culture

Brand names

In some countries, Xalacom is marketed by Viatris after Upjohn was spun off from Pfizer.[2] [3]

Notes and References

  1. Patel SS, Spencer CM . Latanoprost. A review of its pharmacological properties, clinical efficacy and tolerability in the management of primary open-angle glaucoma and ocular hypertension . Drugs Aging . 9. 5 . 363–378 . 1996 . 8922563 . 10.2165/00002512-199609050-00007. 25169085 .
  2. Web site: Pfizer Completes Transaction to Combine Its Upjohn Business with Mylan . Pfizer . Business Wire . 16 November 2020 . 17 June 2024.
  3. Web site: Brands . Viatris . 16 November 2020 . 17 June 2024.

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Latanoprost/timolol".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2025, A B Cryer, All Rights Reserved. Cookie policy.